"Trametinib Promotes MEK Binding to the RAF-Family Pseudokinase KSR."

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

The MEK inhibitor trametinib caused MEK to engage KSR more efficiently than MEK engaged BRAF. Click to show full abstract

The MEK inhibitor trametinib caused MEK to engage KSR more efficiently than MEK engaged BRAF.

Keywords: promotes mek; ksr; trametinib; mek binding; binding raf; trametinib promotes

Journal Title: Cancer discovery
Year Published: 2020

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended